Target intelligence / Profile preview

DNA-dependent Protein Kinase (DNA-PK)

Target
DNA-PK
Molecular classification
Enzyme, Protein Kinase, Serine/threonine protein kinase
01

Overview

DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase complex that plays a central role in the repair of DNA double-strand breaks (DSBs) through the non-homologous end joining (NHEJ) pathway. It is also involved in V(D)J recombination, which is essential for immune system diversity. The complex consists of the catalytic subunit DNA-PKcs and the regulatory Ku heterodimer (Ku70 and Ku80). Activation requires binding to both the Ku heterodimer and exposed DNA ends at DSBs. DNA-PK is essential for repairing DSBs caused by ionizing radiation or other genotoxic stresses and is required for assembling antigen receptor genes in developing lymphocytes. It activates p53 following severe damage to trigger apoptosis if repair capacity is exceeded. Knockout or mutation leads to severe combined immunodeficiency (SCID). DNA-PK is also involved in mitosis regulation and possibly other cellular processes beyond canonical DSB repair pathways.

Other names
DNA-PKcs/Ku heterodimer complexPRKDCDNA-PK catalytic subunitKu70/Ku80
02

Mechanism of action

Inhibition of DNA-PK catalytic activity, preventing DNA repair and inducing apoptosis in cancer cells.

03

Biological functions

DNA repairNon-homologous end joining (NHEJ)V(D)J recombinationCell cycle regulationApoptosisImmune response
04

Disease associations

Severe combined immunodeficiency (SCID)Cancer (potential target due to role in DNA repair)
05

Safety considerations

Potential for off-target effects due to involvement in multiple cellular processes.Inhibition may impair normal DNA repair mechanisms.

Beyond the preview

Go deeper on DNA-dependent Protein Kinase (DNA-PK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-dependent Protein Kinase (DNA-PK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call